# Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection

> **NCT04482673** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of South Carolina** · enrollment: 95 (actual)

## Conditions studied

- COVID-19
- Vitamin D Deficiency
- Respiratory Viral Infection

## Interventions

- **DRUG:** Daily Vitamin D3
- **DRUG:** Daily placebo
- **DRUG:** Bolus vitamin D3
- **DRUG:** Bolus placebo

## Key facts

- **NCT ID:** NCT04482673
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-07-31
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2023-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482673, "Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04482673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*